Id-1 promotes TGF-β1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells

Experimental Cell Research

Volumn 313, Issue 19, 2007, Pages 3983-3999

  Di, Kaijun ^a   Wong, Yong Chuan ^a   Wang, Xianghong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell motility; E cadherin; ERK; HSP27; Id 1; N cadherin; Phosphorylation; Prostate epithelial cells; TGF 1

Indexed keywords

BETA CATENIN; F ACTIN; HEAT SHOCK PROTEIN 27; INHIBITOR OF DIFFERENTIATION 1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL JUNCTION; CELL MIGRATION; CELL MOTILITY; CELL STRESS; CONTROLLED STUDY; CYTOSKELETON; DNA BINDING; DOWN REGULATION; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

EID: 35448988159     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.08.023     Document Type: Article

References (65)

1. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H., Fong S., Itahana Y., Sumida T., Singh J., Coppe J.P., Liu Y., Richards P.C., Bennington J.L., Lee N.M., Debs R.J., and Desprez P.Y. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Cell 61 (1990) 49-59
2. Ruzinova M.B., and Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13 (2003) 410-418
3. Perk J., Iavarone A., and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat. Rev., Cancer 5 (2005) 603-614
4. Desprez P.Y., Hara E., Bissell M.J., and Campisi J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 15 (1995) 3398-3404
5. Desprez P.Y., Lin C.Q., Thomasset N., Sympson C.J., Bissell M.J., and Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol. Cell. Biol. 18 (1998) 4577-4588
6. Fong S., Itahana Y., Sumida T., Singh J., Coppe J.P., Liu Y., Richards P.C., Bennington J.L., Lee N.M., Debs R.J., and Desprez P.Y. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13543-13548
7. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., and Massague J. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
8. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., and Wong Y.C. Over expression of ID-1 in prostate cancer. J. Urol. 167 (2002) 2598-2602
9. Ling M.T., Lau T.C., Zhou C., Chua C.W., Kwok W.K., Wang Q., Wang X., and Wong Y.C. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26 (2005) 1668-1676
10. Timme T.L., Truong L.D., Merz V.W., Krebs T., Kadmon D., Flanders K.C., Park S.H., and Thompson T.C. Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 134 (1994) 1039-1045
11. Truong L.D., Kadmon D., McCune B.K., Flanders K.C., Scardino P.T., and Thompson T.C. Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Human Pathol. 24 (1993) 4-9
12. Steiner M.S., Zhou Z.Z., Tonb D.C., and Barrack E.R. Expression of transforming growth factor-beta 1 in prostate cancer. Endocrinology 135 (1994) 2240-2247
13. Wikstrom P., Stattin P., Franck-Lissbrant I., Damber J.E., and Bergh A. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer. Prostate 37 (1998) 19-29
14. Danielpour D., Kadomatsu K., Anzano M.A., Smith J.M., and Sporn M.B. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res. 54 (1994) 3413-3421
15. Ilio K.Y., Sensibar J.A., and Lee C. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J. Androl. 16 (1995) 482-490
16. Di K., Ling M.T., Tsao S.W., Wong Y.C., and Wang X. Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells. Biol. Cell 98 (2006) 523-533
17. Steiner M.S., and Barrack E.R. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol. 6 (1992) 15-25
18. Morton D.M., and Barrack E.R. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res. 55 (1995) 2596-2602
19. Ao M., Williams K., Bhowmick N.A., and Hayward S.W. Transforming growth factor-{beta} promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 66 (2006) 8007-8016
20. Zavadil J., and Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24 (2005) 5764-5774
21. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev., Cancer 2 (2002) 442-454
22. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev., Mol. Cell Biol. 7 (2006) 131-142
23. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., and Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12 (2001) 27-36
24. Maeda M., Johnson K.R., and Wheelock M.J. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J. Cell Sci. 118 (2005) 873-887
25. Xu L., Chen S., and Bergan R.C. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25 (2006) 2987-2998
26. Guay J., Lambert H., Gingras-Breton G., Lavoie J.N., Huot J., and Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110 (1997) 357-368
27. Hatakeyama D., Kozawa O., Niwa M., Matsuno H., Ito H., Kato K., Tatematsu N., Shibata T., and Uematsu T. Upregulation by retinoic acid of transforming growth factor-beta-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases. Biochim. Biophys. Acta 1589 (2002) 15-30
28. Kammanadiminti S.J., and Chadee K. Suppression of NF-kappaB activation by Entamoeba histolytica in intestinal epithelial cells is mediated by heat shock protein 27. J. Biol. Chem. 281 (2006) 26112-26120
29. Rousseau S., Dolado I., Beardmore V., Shpiro N., Marquez R., Nebreda A.R., Arthur J.S., Case L.M., Tessier-Lavigne M., Gaestel M., Cuenda A., and Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell. Signal. 6 (2006) 6
30. Cornford P.A., Dodson A.R., Parsons K.F., Desmond A.D., Woolfenden A., Fordham M., Neoptolemos J.P., Ke Y., and Foster C.S. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 60 (2000) 7099-7105
31. Tomita K., van Bokhoven A., van Leenders G.J., Ruijter E.T., Jansen C.F., Bussemakers M.J., and Schalken J.A. Cadherin switching in human prostate cancer progression. Cancer Res. 60 (2000) 3650-3654
32. Rocchi P., So A., Kojima S., Signaevsky M., Beraldi E., Fazli L., Hurtado-Coll A., Yamanaka K., and Gleave M. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. 64 (2004) 6595-6602
33. Jaggi M., Nazemi T., Abrahams N.A., Baker J.J., Galich A., Smith L.M., and Balaji K.C. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66 (2006) 193-199
34. Woo P.L., Cercek A., Desprez P.Y., and Firestone G.L. Involvement of the helix-loop-helix protein Id-1 in the glucocorticoid regulation of tight junctions in mammary epithelial cells. J. Biol. Chem. 275 (2000) 28649-28658
35. Kondo M., Cubillo E., Tobiume K., Shirakihara T., Fukuda N., Suzuki H., Shimizu K., Takehara K., Cano A., Saitoh M., and Miyazono K. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 11 (2004) 1092-1101
36. Wiercinska E., Wickert L., Denecke B., Said H.M., Hamzavi J., Gressner A.M., Thorikay M., ten Dijke P., Mertens P.R., Breitkopf K., and Dooley S. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43 (2006) 1032-1041
37. Li Y., Yang J., Luo J.H., Dedhar S., and Liu Y. Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor id1. J. Am. Soc. Nephrol. 18 (2007) 449-460
38. Bright R.K., Vocke C.D., Emmert-Buck M.R., Duray P.H., Solomon D., Fetsch P., Rhim J.S., Linehan W.M., and Topalian S.L. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res. 57 (1997) 995-1002
39. Hayes S.A., Huang X., Kambhampati S., Platanias L.C., and Bergan R.C. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Oncogene 22 (2003) 4841-4850
40. Hajra K.M., Ji X., and Fearon E.R. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18 (1999) 7274-7279
41. Gerthoffer W.T., and Gunst S.J. Invited review: focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J. Appl. Physiol. 91 (2001) 963-972
42. Zavadil J., Bitzer M., Liang D., Yang Y.C., Massimi A., Kneitz S., Piek E., and Bottinger E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6686-6691
43. Ling M.T., Wang X., Ouyang X.S., Lee T.K., Fan T.Y., Xu K., Tsao S.W., and Wong Y.C. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene 21 (2002) 8498-8505
44. Peinado H., Portillo F., and Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48 (2004) 365-375
45. Aberle H., Butz S., Stappert J., Weissig H., Kemler R., and Hoschuetzky H. Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J. Cell Sci. 107 (1994) 3655-3663
46. Umbas R., Schalken J.A., Aalders T.W., Carter B.S., Karthaus H.F., Schaafsma H.E., Debruyne F.M., and Isaacs W.B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52 (1992) 5104-5109
47. Xie L., Law B.K., Chytil A.M., Brown K.A., Aakre M.E., and Moses H.L. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6 (2004) 603-610
48. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5 (1993) 806-811
49. Birchmeier W., and Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198 (1994) 11-26
50. Brembeck F.H., Rosario M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16 (2006) 51-59
51. Peehl D.M. Primary cell cultures as models of prostate cancer development. Endocr.-Relat. Cancer 12 (2005) 19-47
52. Shin K.D., Lee M.Y., Shin D.S., Lee S., Son K.H., Koh S., Paik Y.K., Kwon B.M., and Han D.C. Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J. Biol. Chem. 280 (2005) 41439-41448
53. Gioeli D., Mandell J.W., Petroni G.R., Frierson Jr. H.F., and Weber M.J. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59 (1999) 279-284
54. Lin J.C., Chang S.Y., Hsieh D.S., Lee C.F., and Yu D.S. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells. J. Urol. 174 (2005) 2022-2026
55. Tian Y.C., and Phillips A.O. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am. J. Pathol. 160 (2002) 1619-1628
56. Nakashima A., Katagiri T., and Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280 (2005) 37660-37668
57. Islam S., Carey T.E., Wolf G.T., Wheelock M.J., and Johnson K.R. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 135 (1996) 1643-1654
58. Hazan R.B., Kang L., Whooley B.P., and Borgen P.I. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes. Commun. 4 (1997) 399-411
59. De Wever O., Westbroek W., Verloes A., Bloemen N., Bracke M., Gespach C., Bruyneel E., and Mareel M. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J. Cell Sci. 117 (2004) 4691-4703
60. Haas A.R., and Tuan R.S. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation 64 (1999) 77-89
61. Woods A., Wang G., Dupuis H., Shao Z., and Beier F. Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation and chondrogenesis. J. Biol. Chem. 14 (2007) 14
62. Choo C.K., Ling M.T., Chan K.W., Tsao S.W., Zheng Z., Zhang D., Chan L.C., and Wong Y.C. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames. Prostate 40 (1999) 150-158
63. Rotzer D., Krampert M., Sulyok S., Braun S., Stark H.J., Boukamp P., and Werner S. Id proteins: novel targets of activin action, which regulate epidermal homeostasis. Oncogene 25 (2006) 2070-2081
64. Schindl M., Schoppmann S.F., Strobel T., Heinzl H., Leisser C., Horvat R., and Birner P. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin. Cancer Res. 9 (2003) 779-785
65. Schoppmann S.F., Schindl M., Bayer G., Aumayr K., Dienes J., Horvat R., Rudas M., Gnant M., Jakesz R., and Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int. J. Cancer 104 (2003) 677-682